Tirzepatide (Dual Hormone)

Dual-action weight loss.
Superior metabolic results.

For patients who want the most clinically advanced metabolic weight loss therapy available — tirzepatide activates two pathways where semaglutide activates one.

Start My Tirzepatide Program View All Programs

How it works

Tirzepatide is a dual GIP/GLP-1 receptor agonist — it simultaneously activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual activation produces superior metabolic effects compared to single-agonist GLP-1 therapy.

SURMOUNT-1 clinical trials showed average weight loss of 20–22% of body weight at 72 weeks — meaningfully higher than semaglutide in head-to-head comparisons. Tirzepatide also shows strong benefits for insulin sensitivity, lipid profiles, and blood pressure.

Who it's for

  • Adults seeking the most effective GLP-1 class therapy available
  • Patients who did not achieve adequate results with semaglutide
  • Adults with significant metabolic syndrome or insulin resistance
  • Patients with BMI 30+ or BMI 27+ with weight-related health conditions
  • Anyone seeking maximum metabolic benefit from a physician-supervised program
Program Structure

Tirzepatide is administered as a once-weekly subcutaneous injection. Dosing begins at 2.5mg and escalates every 4 weeks (2.5mg → 5mg → 7.5mg → 10mg → 15mg) based on response and tolerability.

What to Expect

Weeks 1–4

Initial appetite changes and gastric adaptation. Mild GI symptoms are common as the body adjusts to the dual receptor activation. Most patients lose 3–5 pounds.

Weeks 5–8

Significant appetite reduction and improved satiety between meals. Energy and mood improvements become noticeable. Average cumulative loss: 6–10% body weight.

Weeks 9–12

Sustained weight loss with improved metabolic markers. Body composition changes become visible. Average loss: 12–18% body weight by week 12, with continued improvement at full dose.

Ready to start your program?

Our clinical team will review your health history and design a protocol built around your specific goals. Same-week consultations available.

Start My Tirzepatide Program

The services provided have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before beginning any therapy program.